Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis [2] (multiple letters)

New England Journal of Medicine

Volumn 353, Issue 17, 2005, Pages 1858-1860

  Langer, Anatoly ^a   Robinson, Jennifer G ^b   Jaber, Bertrand L ^c   Madias, Nicolaos E ^c   Wanner, Christoph ^d   Krane, Vera ^d   Ritz, Eberhard ^e  

^a CANADIAN HEART RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF IOWA   (United States)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; HEPTANOIC ACID DERIVATIVE; PYRROLE DERIVATIVE;

CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; HEART ARRHYTHMIA; HEART INFARCTION; HEMODIALYSIS; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; BLOOD; NOTE; RENAL REPLACEMENT THERAPY; TREATMENT FAILURE; CEREBROVASCULAR ACCIDENT; MORTALITY; RISK FACTOR; STATISTICAL ANALYSIS;

CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PYRROLES; RENAL DIALYSIS; TREATMENT FAILURE; CEREBROVASCULAR ACCIDENT; DATA INTERPRETATION, STATISTICAL; RISK FACTORS;

EID: 27244452454     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM200510273531720     Document Type: Letter

References (0)